Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

BIO 2026: Cell and gene therapy firms outline their use of AI in manufacturing

From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations.

Latest news

FDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy

With a regulatory route now in place, Regenxbio expects to meet with the FDA again in July, with a BLA resubmission to follow in Q3 2026.

BIO 2026: NVIDIA announces the BioNeMo toolkit for AI agents

The suite of tools is designed to allow AI to carry out R&D work more quickly, reliably, and in a continuous innovation loop.

ŌURA and Lilly join forces to harmonise drug-wearable obesity care

This partnership marks another addition to the growing list of high-profile collaborations between the consumer health and life science sectors.

Haisco and Nuvectis sign licensing deal for two drugs

Haisco will receive $40m upfront and may earn up to $1.4bn in additional milestone payments.

Boehringer and Combotope partner for cancer antibodies

Combotope will deploy its platform to discover antibodies, accompanied by a specific antibody characterisation data package.